Advertisement
Home »

#VisualAbstract: Perioperative Toripalimab Plus Chemotherapy Improves Event-Free Survival in Patients With Resectable Non–Small-Cell Lung Cancer

Jan 24, 2024

ABOUT THE CONTRIBUTORS

Advertisement
Advertisement